Instruction for use: Walsh-asalgin

Dosage form: tablets

Active substance: Acidum acetylsalicylicum

ATX

N02BA51 Acetylsalicylic acid

Pharmacological groups

NSAID - Salicylic acid derivatives

The nosological classification (ICD-10)

K13.7 Other and unspecified oral white lesion: Aspirin burn of the oral mucosa; Gum pain when wearing dentures; Inflammation of the mouth; Inflammation of the oral mucosa after radiation therapy; Inflammation of the oral mucosa after chemotherapy; Inflammation of the oral mucosa; Inflammation of the mucous membranes of the mouth; Inflammatory diseases of the oral cavity; Inflammatory process of pharynx; Disease of the oral mucosa; Injuries to the oral cavity and larynx; Injuries of the oral mucosa; Trophic diseases of the oral mucosa; Trophic diseases of the oral mucosa; Erosive-ulcerative periodontal disease; Erosive-ulcerative lesion of the oral mucosa; Erotic mucous membrane of the oral cavity; Erotic-ulcerative periodontal lesions; Erosive-ulcerative lesions of the mucous membrane of the oral cavity; Radio-epileleitis; Irritation from dentures; Irritation of the oral mucosa with dentures and braces; Oral cavity; When wearing dentures

M79.1 Myalgia: Myofascial pain syndromes; Pain syndrome in musculo-articular diseases; Pain syndrome in chronic inflammatory diseases of the musculoskeletal system; Pain in the muscles; Tenderness of muscles; Muscular soreness in severe physical exertion; Painful conditions of the musculoskeletal system; Pain in the musculoskeletal system; Pain in the muscles; Pain at rest; Muscle aches; Muscle pain; Musculoskeletal pain; Myalgia; Muscle pain; Muscle pain at rest; Muscle pain; Muscular pain of non-rheumatic origin; Muscle pain of rheumatic origin; Acute muscle pain; Rheumatic pain; Myofascial syndrome; Fibromyalgia

M79.2 Neuralgia and neuritis, unspecified: Pain syndrome with neuralgia; Brachialgia; Occipital and intercostal neuralgia; Neuralgia; Neuralgic pain; Neuralgia of intercostal nerves; Neuralgia of the posterior tibial nerve; Neuritis; Neuritis traumatic; Neurological Pain Syndromes; Neurological contractures with spasms; Acute neuritis; Peripheral neuritis; Post-traumatic neuralgia; Severe pain of a neurogenic nature; Chronic neuritis; Essential neuralgia

R50 Fever of unknown origin: Malignant hyperthermia; Hyperthermia malignant

R51 Headache: pain in the head; cephalgia; Pain in sinusitis; Pain in the neck; Pain headache; Headache vasomotor origin; Headache vasomotor origin; Headache with vasomotor disturbances; Headache; Neurological Headache; Continuous headache

R52.2 Other permanent pain: Pain syndrome of non-rheumatic origin; Pain syndrome with vertebrogenic lesions; Pain syndrome with neuralgia; Pain syndrome with burns; Pain syndrome is mild or moderate; Perioperative pain; Moderate and severe pain; Moderately or mildly expressed pain syndrome; Moderate and severe pain syndrome; Ear pain with otitis; Neuropathic pain

Structure and Composition

1 tablet contains acetylsalicylic acid 325 mg; In the package of 60 pcs.

Pharmachologic effect

Mode of action - Anti-inflammatory, antipyretic, antiaggregational, analgesic.

Indications for Walsh-asalgin

Pain syndrome of mild and moderate severity: headache, myalgia, toothache, neuralgia; fever.

Contraindications

Hypersensitivity, gastric ulcer and dodecadactylon, tendency to bleeding, pregnancy.

Side effects

Dyspepsia, erosive-ulcerative gastrointestinal lesions, gastrointestinal bleeding, anemia, allergic reactions.

Interaction

Incompatible with other NSAID, methotrexate, antacids and diuretics. Enhances the effect of heparin, oral anticoagulants and antidiabetics.

Dosing and Administration

Inside, adults and children after 12 years: 1-2 tablets with water every 4 hours, but not more than 12 tablets a day.

Storage conditions of the drug Walsh-asalgin

In the dark place at room temperature.

Keep out of the reach of children.

The shelf life of the drug Walsh-asalgin

2 years.

Do not use beyond the expiration date printed on the package.